This acknowledgement allows Blue Belt Technologies to market STRIDETM outside the United States. Blue Belt Technologies Presidnet & CEO Eric Timko noted “Receiving CE Mark for STRIDETM is an important milestone for Blue Belt as we continue to expand our commercial footprint outside the United States,” according to the press release.
STRIDETM received FDA clearance in June 2014.
To learn more about STRIDETM, click here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
